This page identifies who maintains Psilocybin Research, how records and research views are produced, what is reviewed, and how errors can be corrected.
Policy last reviewed
The tracker indexes bibliographic and registry records related to psilocybin, psilocin, and explicit synonyms. Sources include PubMed, Crossref, Europe PMC, OpenAlex, selected preprint services, and ClinicalTrials.gov. Automated acquisition is followed by normalization, duplicate checks, relevance rules, publication-status classification, and source tracking. Broad coverage is the goal; exhaustive recall is not claimed.
Scheduled source refreshes identify and update records. Deterministic code performs normalization, classification, linking, and deduplication. Manual review is prioritized for ambiguous relevance, conflicting identifiers, unresolved duplicates, incomplete metadata, external comparison candidates, and reported errors. Automatically derived tags are navigation aids and should not be treated as expert clinical judgments.
Trial status, phase, enrollment, sponsor, dates, conditions, interventions, and sites reproduce factual registry fields. Status can lag changes at an individual site. The tracker is for research discovery, not recruitment advice, diagnosis, treatment, or an assessment of safety or efficacy. ClinicalTrials.gov remains the authoritative record for eligibility and contacts.
Public pages, APIs, exports, widgets, analytics, and database downloads use a rights-safe projection. They exclude unverified abstracts, registry descriptions, source-derived keywords, contacts, and unrestricted raw payloads. MIT covers the software; it does not relicense third-party bibliographic content. Dataset selection, arrangement, normalization, original annotations, and validation outputs are documented separately.
Verified corrections are applied to the living tracker with source context preserved. Entries that cannot be validated, are irrelevant, or present unresolved identity conflicts may be quarantined and excluded from public results until they can be resolved. Corrections to fixed Zenodo snapshots are documented through a new version or an explicit record note rather than silently changing an immutable deposit.
Users should open DOI, PubMed, publisher, or registry links before citation, reporting, policy analysis, or clinical interpretation. The live tracker changes over time; reproducible work should cite a fixed Zenodo dataset version and the associated software release. The about page explains architecture and sources, while the data-rights section documents public redistribution limits.
When reporting a problem, include the tracker URL, DOI, PMID or NCT identifier, the field that appears incorrect, and a direct authoritative source. Contact christopher-germann@uni-wh.de. Substantive corrections are checked against source records before publication.
